International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates.
نویسندگان
چکیده
Affiliations: NA Terrault: Hepatology and Transplant Surgery, University of California San Francisco, San Francisco CA GW McCaughan: Australian National Liver Transplant Unit , Centenary Research Institute, Royal Prince Alfred Hospital, Universit y of S ydney, S ydne y, Australia MP Curry: Liver Center, Beth Israel Deaconess Medical Center, Boston, MA, USA E Gane: New Zealand Liver Transplant Unit, Auckland City Hospital Stefano Fagiuoli Gastroenterology and Transplant Hepatology, Papa Giovanni XXIII Hospital – Begamo , Italy J Fung: The Liver Transplant Center, Queen Mary Hospital, Hong Kong K Agarwal: Institute of Liver Studies, Kings College Hospital, London, UK L. Lilly: Toronto Hospital, Toronto, Ontario, Canada SI Strasser; Australian National Liver Transplant Unit, Royal Prince Alfred Hospital and University of Sydney, Sydney, Australia
منابع مشابه
Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management.
Use of organs from donors testing positive for hepatitis B virus (HBV) may safely expand the donor pool. The American Society of Transplantation convened a multidisciplinary expert panel that reviewed the existing literature and developed consensus recommendations for recipient management following the use of organs from HBV positive donors. Transmission risk is highest with liver donors and si...
متن کاملHepatitis C and Kidney Transplantation
Hepatitis C virus (HCV) infection is relatively common among patients with end-stage kidney disease (ESKD) on dialysis and kidney transplant recipients. HCV infection in hemodialysis patients is associated with an increased mortality due to liver cirrhosis and hepatocellular carcinoma. The severity of hepatitis C-related liver disease in kidney transplant candidates may predict patient and graf...
متن کاملReview of Natural History, Benefits and Risk Factors Pediatric Liver Transplantation
Liver or hepatic transplantation (LT) is the replacement of a diseased liver with part or whole healthy liver from another person (allograft). Human liver transplants were first performed by Thomas Starzl in the United States and Roy Calne in Cambridge, England in 1963 and 1967, respectively. Liver transplantation is a viable treatment option for end-stage liver disease and acute liver failure....
متن کاملبررسی تأثیر عفونت هپاتیت ویروسی B و C بر بقای کلیه پیوندی در بیماران دریافت‌کننده کلیه
Background and Aim: Chronic liver disease and its complications are major problems in renal transplant recipients. Hepatitis B and C virus infections are currently the main causes of chronic liver disease in this group, and these may affect allograft outcome. Whether hepatitis B and C virus infections after renal transplantation adversely affect graft and patient survival, remains controver...
متن کاملTreatment of hepatitis C in liver transplant patients: interferon out, direct antiviral combos in.
Although chronic infection with hepatitis C virus (HCV) is the leading indication for liver transplantation in the United States, graft and patient survival rates are reduced because of HCV recurrence after transplant. Interferon-based antiviral treatment administered either before or after transplant to prevent or treat HCV recurrence, respectively, is limited because of poor tolerability and ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Transplantation
دوره 101 5 شماره
صفحات -
تاریخ انتشار 2017